<DOC>
	<DOC>NCT01817569</DOC>
	<brief_summary>The purpose of this investigation is to describe general safety profile of type II Diabetes Mellitus (DM) Japanese patients under exenatide therapy in real world medical practices.</brief_summary>
	<brief_title>Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)</brief_title>
	<detailed_description>Specific Clinical Experience Investigation for long-term use of exenatide (Byetta subcutaneous injection).</detailed_description>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Patient diagnosed with Type 2 Diabetes Mellitus and who is naive patient with Byetta.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Diabetes Mellitus (DM)</keyword>
	<keyword>Byetta</keyword>
	<keyword>Exenatide</keyword>
</DOC>